World Precision Instruments, Inc.

World Precision Instruments, Inc. is dedicated to manufacturing and distributing high-quality laboratory equipment for the life sciences, healthcare, and pharmaceutical markets, providing essential tools for research and clinical applications. Founded in 1967 and headquartered in Sarasota, US, World Precision Instruments, Inc. specializes in laboratory equipment for life sciences.

The company was acquired by The Anderson Group in May 2016, although financial terms were not disclosed. CEO Mark Rutledge leads the firm that continues to focus on its core mission without any significant pivots in strategy or operations since its establishment. World Precision Instruments (WPI) specializes in the manufacturing and distribution of high-quality laboratory equipment and supplies tailored for the life sciences, pharmaceutical, healthcare, and industrial markets. Their core product offerings include micromanipulators critical for applications in electrophysiology and micro/nanofabrication, alongside precision surgical instruments such as scalpels, surgical scissors, and thumb forceps.

WPI develops innovative solutions for complex research needs, including tools for drug testing and organ-on-chip systems, particularly focusing on transepithelial electrical resistance (TEER) technology. These products primarily serve university research labs, life science researchers, microsurgeons, and industries involved in medical device development, marketed globally across North America, Europe, and Asia. WPI generates revenue through the direct sale of its innovative laboratory instruments and supplies, typically sold through B2B channels to research institutions, universities, and healthcare facilities. The company offers customized solutions to meet specific client needs, with flagship products like the EVOM™ Chip and specialized micromanipulators driving significant sales.

WPI also maintains partnerships with distributors and retailers to extend market reach, enhancing its presence in varied geographical regions. Following the acquisition in May 2016, WPI aims to expand its product range and enter new markets. The company is currently designing new laboratory instruments targeted for release in the next 12 months. Plans include expanding into key markets in Europe and Asia by 2025, utilizing funding from the 2016 acquisition to support these initiatives.